Rekombinanter Dopamine Receptor d1 Antikörper (C-Term)
Kurzübersicht für Rekombinanter Dopamine Receptor d1 Antikörper (C-Term) (ABIN6943115)
Target
Alle Dopamine Receptor d1 (DRD1) Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- DRD1 Recombinant Antibody
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- Human Dopamine Receptor D1 between 400 to C-terminus
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:500-2000)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 0.01M TBS ( pH 7.4), 1 % BSA, 0.02 % Proclin 300, and 50 % Glycerol
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))
-
Andere Bezeichnung
- DRD1
-
Hintergrund
-
Synonyms: D(1A) dopamine receptor, Dopamine D1 receptor, DRD1
Background: Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.
-
Gen-ID
- 1812
-
UniProt
- P21728
-
Pathways
- cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity
Target
-